http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103520205-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2375e063c948a982b0f5b4636ab3809
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-765
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-702
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-14
filingDate 2012-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a2c3e281c5f3799b6ef23fde3b174b9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c02b567de0ca85299855550f7d75c4d4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_045e1f3343788561cd18b068f6394983
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04fcef2a6bc0bdbc8c8120cccc8b0a09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bff2bf7d1cb266f1f685fefb057956c9
publicationDate 2014-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103520205-A
titleOfInvention Pharmaceutical composition for laxative and bowel cleansing
abstract The present invention provides a pharmaceutical composition for laxative and bowel cleansing, wherein the composition comprises polyethylene glycol and stachyose, wherein the weight ratio range of polyethylene glycol and stachyose is 0.656 ~13.125:1, optionally, the composition further includes one or more alkaline earth metal salts capable of maintaining osmotic pressure and electrolyte balance. The pharmaceutical composition of the present invention, because the content of polyethylene glycol is greatly reduced and contains stachyose, it not only reduces adverse reactions such as nausea, vomiting, abdominal pain, abdominal distension, allergies, frequent diarrhea, but also has the ability to treat the recurrence rate of constipation Low, no air bubbles for bowel cleansing, high intestinal cleansing rate, low intestinal infection rate, short time required to complete intestinal cleansing, and high compliance rate, so it is more conducive to the clinical treatment of constipation and preoperative intestinal Clean and ready.
priorityDate 2012-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67510
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415737037

Total number of triples: 21.